Promotion of cellular NAD+ anabolism: Therapeutic potential for oxidative stress in ageing and alzheimer's disease

N Braidy, G Guillemin, R Grant - Neurotoxicity Research, 2008 - Springer
Oxidative imbalance is a prominent feature in Alzheimer's disease and ageing. Increased
levels of reactive oxygen species (ROS) can result in disordered cellular metabolism due to …

Dysfunction of mitochondria in Alzheimer's disease: ANT and VDAC interact with toxic proteins and aid to determine the fate of brain cells

A Atlante, D Valenti, V Latina, G Amadoro - International journal of …, 2022 - mdpi.com
Alzheimer's disease (AD), certainly the most widespread proteinopathy, has as classical
neuropathological hallmarks, two groups of protein aggregates: senile plaques and …

Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders

B Polis, AO Samson - Neural regeneration research, 2020 - journals.lww.com
Alzheimer's disease is an incurable chronic neurodegenerative disorder and the leading
cause of dementia, imposing a growing economic burden upon society. The disease …

Amyloid β peptide compromises neural stem cell fate by irreversibly disturbing mitochondrial oxidative state and blocking mitochondrial biogenesis and dynamics

MF Ribeiro, T Genebra, AC Rego… - Molecular …, 2019 - Springer
Alzheimer's disease (AD) is the most common neurodegenerative disease and is
characterized by the accumulation of amyloid β peptide (Aβ). Although most AD mouse …

[HTML][HTML] L-Norvaline reverses cognitive decline and synaptic loss in a murine model of Alzheimer's disease

B Polis, KD Srikanth, E Elliott, H Gil-Henn, AO Samson - Neurotherapeutics, 2018 - Elsevier
The urea cycle is strongly implicated in the pathogenesis of Alzheimer's disease (AD).
Arginase-I (ARGI) accumulation at sites of amyloid-beta (Aβ) deposition is associated with L …

Sex‐specific alterations in NAD+ metabolism in 3xTg Alzheimer's disease mouse brain assessed by quantitative targeted LC‐MS

V van Der Velpen, N Rosenberg… - Journal of …, 2021 - Wiley Online Library
Levels of nicotinamide adenine dinucleotide (NAD+) are known to decline with age and
have been associated with impaired mitochondrial function leading to neurodegeneration, a …

Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release

IL Ferreira, E Ferreiro, J Schmidt, JM Cardoso… - Neurobiology of …, 2015 - Elsevier
Early cognitive deficits in Alzheimer's disease (AD) seem to be correlated to dysregulation of
glutamate receptors evoked by amyloid-beta (Aβ) peptide. Aβ interference with the activity of …

[HTML][HTML] Dysfunctional mitochondrial bioenergetics and synaptic degeneration in Alzheimer disease

J Tang, A Oliveros, MH Jang - International neurourology journal, 2019 - ncbi.nlm.nih.gov
Synapses are sites of high energy demand which are dependent on high levels of
mitochondrial derived adenosine triphosphate. Mitochondria within synaptic structures are …

Urolithin A suppresses high glucose-induced neuronal amyloidogenesis by modulating TGM2-dependent ER-mitochondria contacts and calcium homeostasis

HJ Lee, YH Jung, GE Choi, JS Kim, CW Chae… - Cell Death & …, 2021 - nature.com
Hyperglycemia in diabetes mellitus (DM) patients is a causative factor for amyloidogenesis
and induces neuropathological changes, such as impaired neuronal integrity …

Streptozotocin-induced astrocyte mitochondrial dysfunction is ameliorated by FTO inhibitor MO-I-500

Z Cockova, O Honc, P Telensky, MJ Olsen… - ACS Chemical …, 2021 - ACS Publications
The pathogenesis of Alzheimer's disease (AD), the most prevalent form of dementia,
remains unclear. Over the past few years, evidence has accumulated indicating that …